Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
August 11, 2008
- Isentress Key Drug in HIV Treatment: Banyu
August 11, 2008
- Tokushukai Committed to Settling Prices by End of September
August 11, 2008
- R&D NEWS IN BRIEF
August 11, 2008
- MSNW Supports Rational Drug Pricing
August 11, 2008
- GENERICS NEWS IN BRIEF
August 11, 2008
- JPMA Members Improving Distribution Business Practices: Mr Negi
August 11, 2008
- JRCS Considers Joint Purchase of Generics
August 11, 2008
- Price Settlement Rate Remains at 18% as of June 30: NPhA
August 11, 2008
- Gov't Plans to Create 20 "Super Tokku"
August 11, 2008
- Avapro Holds Top Position 2 Months in a Row: Rep Track Survey
August 11, 2008
- More Research Centers in China
August 11, 2008
- Matsumotokiyoshi Acquires Mogi Pharmaceutical
August 11, 2008
- 9 Asian Studies Started in 2007
August 11, 2008
- Suzuken to Acquire a Dispensing Pharmacy Chain
August 11, 2008
- siRNA Therapeutic to Enter PI in 2009: GeneCare
August 11, 2008
- GSK's New Business Strategy Puts Emphasis on Japanese Market
August 11, 2008
- Amgen Shows Inhibition of Fractures by Denosumab
August 11, 2008
- MTPC Licenses Drug for Hyperparathyroidism from Cytochroma of Canada
August 11, 2008
- Nippon Chemiphar Expects 34.3% Growth Rate for Generics
August 11, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…